uniQure N.V. Ordinary Shares vs TD SYNNEX Corporation Common Stock — how do they compare? uniQure N.V. Ordinary Shares trades at $20.71 (market cap $1.45B), while TD SYNNEX Corporation Common Stock trades at $255 (market cap $21.04B). The key difference: TD SYNNEX Corporation Common Stock is far larger — about 14.5× uniQure N.V. Ordinary Shares's market cap, and TD SYNNEX Corporation Common Stock pays a 0.73% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold uniQure N.V. Ordinary Shares for 0 Days and TD SYNNEX Corporation Common Stock for 0 Days on average.
| QURE | SNX | |
|---|---|---|
Market Cap | $1.45B | $21.04B |
Volume | 3,323,243 | 641,037 |
Sector | Health | Technology |
52-Week High | $70.59 | $290.14 |
52-Week Low | $9.03 | $142.42 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $707.46M | $25.81B |
Dividend Yield | — | 0.73% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →TD SYNNEX Corporation is a global IT distributor and solutions aggregator that distributes endpoint devices and data-center technologies from technology vendors to resellers and customers worldwide.
Read more on SNX →